Bristol-Myers Squibb Company's Revenue
- Bristol-Myers Squibb Company's annual revenue was $48.30 B in fiscal year 2024. The annual revenue increased $3.29 B from $45.01 B (in 2023) to $48.30 B (in 2024), representing a 7.32% year-over-year growth.
- Bristol-Myers Squibb Company's quarterly revenue was $12.34 B in the quarter ending Dec 2024. The quarterly revenue increased $865.00 M from $11.48 B (in Q4: Sept 2023) to $12.34 B (in Q4: Sept 2024), representing a 7.54% year-over-year growth.
- The highest annual revenue for Bristol-Myers Squibb Company was $48.30 B in fiscal year 2024.
- The lowest annual revenue was $16.56 B in fiscal year 2015.
- The average revenue was $33.38 B.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2015 - 2024):
Learn more about Bristol-Myers Squibb Company's Revenue by Segment and Revenue by Region.
Check out competitors to Bristol-Myers Squibb Company in a side-by-side comparison.
Explore additional financial metrics for Bristol-Myers Squibb Company.
Definition of Revenue :
| 2014 | 15879000000.00 |
|---|---|
| 2015 | 16560000000.00 |
| 2016 | 19427000000.00 |
| 2017 | 20776000000.00 |
| 2018 | 22561000000.00 |
| 2019 | 26145000000.00 |
| 2020 | 42518000000.00 |
| 2021 | 46385000000.00 |
| 2022 | 46159000000.00 |
| 2023 | 45006000000.00 |
| 2024 | 48300000000.00 |
| Mar 2015 | 4041000000.00 |
|---|---|
| Jun 2015 | 4163000000.00 |
| Sep 2015 | 4069000000.00 |
| Dec 2015 | 4287000000.00 |
| Mar 2016 | 4391000000.00 |
| Jun 2016 | 4871000000.00 |
| Sep 2016 | 4922000000.00 |
| Dec 2016 | 5243000000.00 |
| Mar 2017 | 4929000000.00 |
| Jun 2017 | 5144000000.00 |
| Sep 2017 | 5254000000.00 |
| Dec 2017 | 5449000000.00 |
| Mar 2018 | 5193000000.00 |
| Jun 2018 | 5704000000.00 |
| Sep 2018 | 5691000000.00 |
| Dec 2018 | 5973000000.00 |
| Mar 2019 | 5920000000.00 |
| Jun 2019 | 6273000000.00 |
| Sep 2019 | 6007000000.00 |
| Dec 2019 | 7945000000.00 |
| Mar 2020 | 10781000000.00 |
| Jun 2020 | 10129000000.00 |
| Sep 2020 | 10540000000.00 |
| Dec 2020 | 11068000000.00 |
| Mar 2021 | 11073000000.00 |
| Jun 2021 | 11703000000.00 |
| Sep 2021 | 11624000000.00 |
| Dec 2021 | 11985000000.00 |
| Mar 2022 | 11648000000.00 |
| Jun 2022 | 11887000000.00 |
| Sep 2022 | 11218000000.00 |
| Dec 2022 | 11406000000.00 |
| Mar 2023 | 11337000000.00 |
| Jun 2023 | 11226000000.00 |
| Sep 2023 | 10966000000.00 |
| Dec 2023 | 11477000000.00 |
| Mar 2024 | 11865000000.00 |
| Jun 2024 | 12201000000.00 |
| Sep 2024 | 11892000000.00 |
| Dec 2024 | 12342000000.00 |
2024
Bristol-Myers Squibb Company's annual revenue was $48.30 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $11.87 B(Q1: Mar 2024), $12.20 B(Q2: Jun 2024), $11.89 B(Q3: Sep 2024), $12.34 B(Q4: Dec 2024) in fiscal year 2024.
2023
Bristol-Myers Squibb Company's annual revenue was $45.01 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $11.34 B(Q1: Mar 2023), $11.23 B(Q2: Jun 2023), $10.97 B(Q3: Sep 2023), $11.48 B(Q4: Dec 2023) in fiscal year 2023.
2022
Bristol-Myers Squibb Company's annual revenue was $46.16 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $11.65 B(Q1: Mar 2022), $11.89 B(Q2: Jun 2022), $11.22 B(Q3: Sep 2022), $11.41 B(Q4: Dec 2022) in fiscal year 2022.
2021
Bristol-Myers Squibb Company's annual revenue was $46.39 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $11.07 B(Q1: Mar 2021), $11.70 B(Q2: Jun 2021), $11.62 B(Q3: Sep 2021), $11.99 B(Q4: Dec 2021) in fiscal year 2021.
2020
Bristol-Myers Squibb Company's annual revenue was $42.52 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $10.78 B(Q1: Mar 2020), $10.13 B(Q2: Jun 2020), $10.54 B(Q3: Sep 2020), $11.07 B(Q4: Dec 2020) in fiscal year 2020.
2019
Bristol-Myers Squibb Company's annual revenue was $26.15 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $5.92 B(Q1: Mar 2019), $6.27 B(Q2: Jun 2019), $6.01 B(Q3: Sep 2019), $7.95 B(Q4: Dec 2019) in fiscal year 2019.
2018
Bristol-Myers Squibb Company's annual revenue was $22.56 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $5.19 B(Q1: Mar 2018), $5.70 B(Q2: Jun 2018), $5.69 B(Q3: Sep 2018), $5.97 B(Q4: Dec 2018) in fiscal year 2018.
2017
Bristol-Myers Squibb Company's annual revenue was $20.78 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $4.93 B(Q1: Mar 2017), $5.14 B(Q2: Jun 2017), $5.25 B(Q3: Sep 2017), $5.45 B(Q4: Dec 2017) in fiscal year 2017.
2016
Bristol-Myers Squibb Company's annual revenue was $19.43 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $4.39 B(Q1: Mar 2016), $4.87 B(Q2: Jun 2016), $4.92 B(Q3: Sep 2016), $5.24 B(Q4: Dec 2016) in fiscal year 2016.
2015
Bristol-Myers Squibb Company's annual revenue was $16.56 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $4.04 B(Q1: Mar 2015), $4.16 B(Q2: Jun 2015), $4.07 B(Q3: Sep 2015), $4.29 B(Q4: Dec 2015) in fiscal year 2015.
| 2014 | 0 |
|---|---|
| 2015 | +4.29 |
| 2016 | +17.31 |
| 2017 | +6.94 |
| 2018 | +8.59 |
| 2019 | +15.89 |
| 2020 | +62.62 |
| 2021 | +9.09 |
| 2022 | -0.49 |
| 2023 | -2.50 |
| 2024 | +7.32 |
| Q1: Mar 15 | 6.04 |
|---|---|
| Q2: Jun 15 | 7.05 |
| Q3: Sep 15 | 3.77 |
| Q4: Dec 15 | 0.68 |
| Q1: Mar 16 | 8.66 |
| Q2: Jun 16 | 17.01 |
| Q3: Sep 16 | 20.96 |
| Q4: Dec 16 | 22.30 |
| Q1: Mar 17 | 12.25 |
| Q2: Jun 17 | 5.60 |
| Q3: Sep 17 | 6.75 |
| Q4: Dec 17 | 3.93 |
| Q1: Mar 18 | 5.36 |
| Q2: Jun 18 | 10.89 |
| Q3: Sep 18 | 8.32 |
| Q4: Dec 18 | 9.62 |
| Q1: Mar 19 | 14.00 |
| Q2: Jun 19 | 9.98 |
| Q3: Sep 19 | 5.55 |
| Q4: Dec 19 | 33.02 |
| Q1: Mar 20 | 82.11 |
| Q2: Jun 20 | 61.47 |
| Q3: Sep 20 | 75.46 |
| Q4: Dec 20 | 39.31 |
| Q1: Mar 21 | 2.71 |
| Q2: Jun 21 | 15.54 |
| Q3: Sep 21 | 10.28 |
| Q4: Dec 21 | 8.29 |
| Q1: Mar 22 | 5.19 |
| Q2: Jun 22 | 1.57 |
| Q3: Sep 22 | -3.49 |
| Q4: Dec 22 | -4.83 |
| Q1: Mar 23 | -2.67 |
| Q2: Jun 23 | -5.56 |
| Q3: Sep 23 | -2.25 |
| Q4: Dec 23 | 0.62 |
| Q1: Mar 24 | 4.66 |
| Q2: Jun 24 | 8.69 |
| Q3: Sep 24 | 8.44 |
| Q4: Dec 24 | 7.54 |
2024
Bristol-Myers Squibb Company’s annual revenue increased +7.32% during fiscal year 2024 compared to 2023. It represents a growth of $3.29 B from $45.01 B (in 2023) to $48.30 B (in 2024).
2023
Bristol-Myers Squibb Company’s annual revenue decreased -2.50% during fiscal year 2023 compared to 2022. It represents a decline of -$1.15 B from $46.16 B (in 2022) to $45.01 B (in 2023).
2022
Bristol-Myers Squibb Company’s annual revenue decreased -0.49% during fiscal year 2022 compared to 2021. It represents a decline of -$226.00 M from $46.39 B (in 2021) to $46.16 B (in 2022).
2021
Bristol-Myers Squibb Company’s annual revenue increased +9.09% during fiscal year 2021 compared to 2020. It represents a growth of $3.87 B from $42.52 B (in 2020) to $46.39 B (in 2021).
2020
Bristol-Myers Squibb Company’s annual revenue increased +62.62% during fiscal year 2020 compared to 2019. It represents a growth of $16.37 B from $26.15 B (in 2019) to $42.52 B (in 2020).
2019
Bristol-Myers Squibb Company’s annual revenue increased +15.89% during fiscal year 2019 compared to 2018. It represents a growth of $3.58 B from $22.56 B (in 2018) to $26.15 B (in 2019).
2018
Bristol-Myers Squibb Company’s annual revenue increased +8.59% during fiscal year 2018 compared to 2017. It represents a growth of $1.79 B from $20.78 B (in 2017) to $22.56 B (in 2018).
2017
Bristol-Myers Squibb Company’s annual revenue increased +6.94% during fiscal year 2017 compared to 2016. It represents a growth of $1.35 B from $19.43 B (in 2016) to $20.78 B (in 2017).
2016
Bristol-Myers Squibb Company’s annual revenue increased +17.31% during fiscal year 2016 compared to 2015. It represents a growth of $2.87 B from $16.56 B (in 2015) to $19.43 B (in 2016).
2015
Bristol-Myers Squibb Company’s annual revenue increased +4.29% during fiscal year 2015 compared to 2014. It represents a growth of $681.00 M from $15.88 B (in 2014) to $16.56 B (in 2015).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2024 | $48.30 B | +7.32% |
| 2023 | $45.01 B | -2.50% |
| 2022 | $46.16 B | -0.49% |
| 2021 | $46.39 B | +9.09% |
| 2020 | $42.52 B | +62.62% |
| 2019 | $26.15 B | +15.89% |
| 2018 | $22.56 B | +8.59% |
| 2017 | $20.78 B | +6.94% |
| 2016 | $19.43 B | +17.31% |
| 2015 | $16.56 B | +4.29% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q4: Dec 24 | $12.34 B | 7.54% |
| Q3: Sep 24 | $11.89 B | 8.44% |
| Q2: Jun 24 | $12.20 B | 8.69% |
| Q1: Mar 24 | $11.87 B | 4.66% |
| Q4: Dec 23 | $11.48 B | 0.62% |
| Q3: Sep 23 | $10.97 B | -2.25% |
| Q2: Jun 23 | $11.23 B | -5.56% |
| Q1: Mar 23 | $11.34 B | -2.67% |
| Q4: Dec 22 | $11.41 B | -4.83% |
| Q3: Sep 22 | $11.22 B | -3.49% |
| Q2: Jun 22 | $11.89 B | 1.57% |
| Q1: Mar 22 | $11.65 B | 5.19% |
| Q4: Dec 21 | $11.99 B | 8.29% |
| Q3: Sep 21 | $11.62 B | 10.28% |
| Q2: Jun 21 | $11.70 B | 15.54% |
| Q1: Mar 21 | $11.07 B | 2.71% |
| Q4: Dec 20 | $11.07 B | 39.31% |
| Q3: Sep 20 | $10.54 B | 75.46% |
| Q2: Jun 20 | $10.13 B | 61.47% |
| Q1: Mar 20 | $10.78 B | 82.11% |
| Q4: Dec 19 | $7.95 B | 33.02% |
| Q3: Sep 19 | $6.01 B | 5.55% |
| Q2: Jun 19 | $6.27 B | 9.98% |
| Q1: Mar 19 | $5.92 B | 14.00% |
| Q4: Dec 18 | $5.97 B | 9.62% |
| Q3: Sep 18 | $5.69 B | 8.32% |
| Q2: Jun 18 | $5.70 B | 10.89% |
| Q1: Mar 18 | $5.19 B | 5.36% |
| Q4: Dec 17 | $5.45 B | 3.93% |
| Q3: Sep 17 | $5.25 B | 6.75% |
| Q2: Jun 17 | $5.14 B | 5.60% |
| Q1: Mar 17 | $4.93 B | 12.25% |
| Q4: Dec 16 | $5.24 B | 22.30% |
| Q3: Sep 16 | $4.92 B | 20.96% |
| Q2: Jun 16 | $4.87 B | 17.01% |
| Q1: Mar 16 | $4.39 B | 8.66% |
| Q4: Dec 15 | $4.29 B | 0.68% |
| Q3: Sep 15 | $4.07 B | 3.77% |
| Q2: Jun 15 | $4.16 B | 7.05% |
| Q1: Mar 15 | $4.04 B | 6.04% |
